Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Principia Biopharma Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16
Revenues69.15.20.0
            Revenue growth1217.6%  
Cost of goods sold0.00.00.0
Gross profit69.15.20.0
            Gross margin100.0%100.0% 
Research and development40.525.422.3
General and administrative11.56.44.8
EBIT17.1-26.6-27.1
            EBIT margin24.8%-506.7% 
Pre-tax income18.2-28.7-30.6
Income taxes0.00.00.0
            Tax rate0.0%  
Net income4.9-28.7-30.6
            Net margin7.1%-546.9% 
 
Diluted EPS$0.57($50.37)($59.89)
Shares outstanding (diluted)8.60.60.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy